The Genetic Challenges and Opportunities in Advanced Heart Failure.

Fady Hannah-Shmouni,S. Seidelmann,S. Sirrs,A. Mani,D. Jacoby

Published 2015 in Canadian Journal of Cardiology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2015
Venue
Canadian Journal of Cardiology
Publication date
2015-11-01
Fields of study
Medicine
Identifiers
DOI 10.1016/j.cjca.2015.07.735 PMID 26518444 PMCID PMC5423787
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar, PubMed

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

Determining the prevalence of McArdle disease from gene frequency by analysis of next generation sequencing data
2015cited by this paper
Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?
2014cited by this paper
Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart
2014cited by this paper
Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans.
2014cited by this paper
The promise and challenges of next-generation genome sequencing for clinical care.
2014cited by this paper
Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy: Under-Recognized Subset of Candidates for Heart Transplant
2014cited by this paper
Mitochondria in Cardiovascular Physiology and Disease Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance
2014cited by this paper
Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data
2014cited by this paper
Refractory high output heart failure in a patient with primary mitochondrial respiratory chain disease.
2014cited by this paper
Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy.
2014cited by this paper
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
2014cited by this paper
Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS)
2014cited by this paper
Genetic testing for inherited cardiac disease
2013cited by this paper
Predictors of Disease Progression in Pediatric Dilated Cardiomyopathy
2013cited by this paper
Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
2013cited by this paper
Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
2013cited by this paper
Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients
2013cited by this paper
Disorders of fatty acid oxidation.
2013cited by this paper
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.
2013cited by this paper
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
2013cited by this paper
Genetic mutations and mechanisms in dilated cardiomyopathy.
2013cited by this paper
Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.
2013cited by this paper
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
2013cited by this paper
Intermittent rhabdomyolysis with adult onset associated with a mutation in the ACADVL gene.
2013cited by this paper
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013cited by this paper
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
2013cited by this paper
Heart failure.
2013cited by this paper
Outcomes of adults with restrictive cardiomyopathy after heart transplantation.
2012cited by this paper
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.
2012cited by this paper
Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
2012cited by this paper
Monogenic mitochondrial disorders.
2012cited by this paper
Recurrent exercise-induced rhabdomyolysis
2012cited by this paper
Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new.
2012cited by this paper
Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
2012cited by this paper
A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations
2012cited by this paper
30-year follow-up of a patient with classic citrullinemia.
2012cited by this paper
Truncations of titin causing dilated cardiomyopathy.
2012cited by this paper
Left ventricular noncompaction cardiomyopathy: an overdiagnosed disease.
2012cited by this paper
Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.
2012cited by this paper
Danon disease: focusing on heart
2012cited by this paper
Arrhythmogenic right ventricular cardiomyopathy.
2012cited by this paper
The Fabry cardiomyopathy: models for the cardiologist.
2011cited by this paper
Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals
2011cited by this paper
Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice
2011cited by this paper
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2011cited by this paper
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
2011cited by this paper
Exome sequencing as a tool for Mendelian disease gene discovery
2011cited by this paper
Predictors of cardiac hepatopathy in patients with right heart failure
2011cited by this paper
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci
2011cited by this paper
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
2011cited by this paper
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
2011cited by this paper
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
2011cited by this paper
Multisystem Disorder in Late-Onset Chronic Progressive External Ophthalmoplegia
2011cited by this paper
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
2011cited by this paper
Heart failure: advances through genomics
2011cited by this paper
Epidemiology and risk profile of heart failure
2011cited by this paper
Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic Cardiomyopathy
2011cited by this paper
Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation
2011cited by this paper
Lifetime Costs of Medical Care After Heart Failure Diagnosis
2011cited by this paper
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics.
2011cited by this paper
Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry: A Prospective Meta-Analysis From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium
2010cited by this paper
Genetics of restrictive cardiomyopathy.
2010cited by this paper
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study
2010cited by this paper
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women
2010cited by this paper
Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening
2010cited by this paper
Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.
2010cited by this paper
Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
2010cited by this paper
Glycogen storage disease type III in the Irish population
2010cited by this paper
Heart Transplantation in Women With Dilated Cardiomyopathy
2010cited by this paper
Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study
2010cited by this paper
Lack of Uniform Progression of Endocardial Scar in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Ventricular Tachycardia
2010cited by this paper
Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
2010cited by this paper
Left ventricular noncompaction
2009cited by this paper
HFE-associated hereditary hemochromatosis
2009cited by this paper
Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
2009cited by this paper
Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives
2009cited by this paper
Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β‐Blocker Users
2009cited by this paper
Severe Hypertrophic Cardiomyopathy in an Infant with a Novel PRKAG2 Gene Mutation: Potential Differences Between Infantile and Adult Onset Presentation
2009cited by this paper
High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
2009cited by this paper
Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
2009cited by this paper
Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy: Evidence for a Better Outcome With Early Treatment
2009cited by this paper
ACE Insertion/Deletion, But Not −240A>T Polymorphism, Modulates the Severity in Heart Failure
2008cited by this paper
Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy
2008cited by this paper
Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats.
2008cited by this paper
Prevalence of mitochondrial DNA disease in adults
2008cited by this paper
Reversibility of PRKAG2 Glycogen-Storage Cardiomyopathy and Electrophysiological Manifestations
2008cited by this paper
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
2007cited by this paper
MicroRNA-133 controls cardiac hypertrophy
2007cited by this paper
Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.
2007cited by this paper
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?
2007cited by this paper
Arg389Gly-&bgr;1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol
2007cited by this paper
Cardiac manifestations in oxidative phosphorylation disorders of childhood.
2007cited by this paper
Relation of β2-Adrenoceptor Haplotype to Risk of Death and Heart Transplantation in Patients With Heart Failure
2007cited by this paper
Synergistic polymorphisms of &bgr;1 and &agr;2C-adrenergic receptors and the influence on left ventricular ejection fraction response to &bgr;-blocker therapy in heart failure
2007cited by this paper
A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
2006cited by this paper
Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd
2006cited by this paper
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
2006cited by this paper
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.
2006cited by this paper
Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice
2006cited by this paper
Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
2005cited by this paper

CITED BY

Fetal adnexa-derived allogeneic mesenchymal stem cells for cardiac regeneration: the future trend of cell-based therapy for age-related adverse conditions
2025cites this paper
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
2021cites this paper
Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.
2021cites this paper
Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults
2017cites this paper
Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications
2017cites this paper
Genetic determinants of myocardial dysfunction
2016cites this paper
Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.
2016cites this paper